165 related articles for article (PubMed ID: 3607983)
1. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
2. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
4. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
5. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Carmignani F; Piscopello L; Sammartini C
Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
[TBL] [Abstract][Full Text] [Related]
6. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers for endocrine neoplasms].
Okamoto T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid carcinoma].
Tamaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
10. The use of octreotide in the treatment of medullary thyroid carcinoma.
Frank-Raue K; Ziegler R; Raue F
Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
[TBL] [Abstract][Full Text] [Related]
11. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
[TBL] [Abstract][Full Text] [Related]
12. Humoral markers for thyroid carcinoma.
Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
[TBL] [Abstract][Full Text] [Related]
13. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
Calmettes C; Moukhtar MS; Milhaud G
Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
[TBL] [Abstract][Full Text] [Related]
15. [Serum thyroglobulin in thyroid cancer and other thyroid diseases].
Demidchik EP; Kruglova NE; Minaĭlo TI; Gauptman AE; Koren' TA; Gedrevich ZE; Sevkovskiĭ IaI
Lab Delo; 1990; (7):16-8. PubMed ID: 1699058
[TBL] [Abstract][Full Text] [Related]
16. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
Pichon MF; Coquin G; Fauveau C; Rey A
Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].
Miyauchi A
Gan No Rinsho; 1988 May; 34(6):739-43. PubMed ID: 3379756
[TBL] [Abstract][Full Text] [Related]
18. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
Gerardi G; De Angelis P
Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
[TBL] [Abstract][Full Text] [Related]
19. Serum thyroglobulin in differentiated thyroid carcinoma.
Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
[TBL] [Abstract][Full Text] [Related]
20. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]